“���������������������������op������r���:za33���”的搜索结果，显示 1-10 项，共有 977 项

1. 血液科 - 临床试验 - 妙佑医疗国际

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

2. Untitled

   Page 1.

3. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA ...

5. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

6. 血液科- 临床试验- 妙佑医疗国际

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

7. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

8. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

9. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... operative patients. Advances in endonasal ... There are few studies using prehabilitation to improve peri-operative outcomes in patients undergoing cancer surgery ...